Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Longeveron Inc
LGVN
Healthcare
Biotechnology
Longeveron Inc. is a clinical-stage biotechnology company. The Company is focused on developing cellular therapies for specific aging-related and life-threatening conditions. The Company's lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy...
adult donors. The Company is primarily focused on three pipeline indications, which include Hypoplastic Left Heart Syndrome (HLHS), Alzheimer’s disease (AD) and Aging-related Frailty. Its Lomecel-B has multiple mechanisms of action encompassing pro-vascular, pro-regenerative, anti- inflammatory, and tissue repair and healing effects with potential applications across a spectrum of disease areas. The Company has bone marrow supply contracts in with two suppliers: the Oklahoma Blood Institute and Vista Health Research.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:LGVN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 15, 2024 8:30am
New Press Release - Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B(TM) in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it has been accepted for a Featured Research Oral Presentation to present the Company’s CLEAR MIND Phase 2a study results. CLEAR...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 11, 2024 5:17pm
New Press Release - Longeveron Announces Closing of $5.2 Million Public Offering
MIAMI, April 11, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s...
read article.
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(229)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Apr 09, 2024 6:45pm
InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) Releases
JUST IN: $LGVN InvestorNewsBreaks - Longeveron Inc. (NASDAQ: LGVN) Releases Pricing for Mulitmillion-Dollar Public OfferingLongeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 2:16pm
LGVN.....What did I tell you????
Say god-night ..... Richard !!!!!!!!!!!!!!!!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 08, 2024 2:15pm
New Press Release - Longeveron Announces Pricing of $5.25 Million Public Offering
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 12:19pm
LGVN.... Has to hold here at $3.20 or else....
It's done ; ) GLTA Me no position
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 9:51am
LGVN...2nd scalp ...same as the 1st ; )
I'm Henry the VIII I am ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 9:46am
LGVN.....Bot the dip and sold the rip ; )
Thanks for the Monday scalp ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 8:48am
LGVN.....ahhhh isn't that nice of the CEO to give the .....
Shareholders an update......right before he "slits everyones throats" with high priced paper....As I mentioned .....it's up in PM trading ; ) Longeveron Issues Letter to Shareholders
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 08, 2024 8:30am
New Press Release - Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
MIAMI, April 08, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that the Company’s CEO, Wa’el Hashad, issued the following letter to Longeveron shareholders. Dear Shareholders,I am delighted to...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 08, 2024 7:54am
LGVN....Up in AH trading on Friday close....
Up another $1 in PM trading this a.m on no news....might get another push higher before the close But this is just another pump for a P.O set up....read the SEC S-1A XBRL Viewer (sec.gov)
(59)
•••
Nibinator
X
View Profile
View Bullboard History
Post by
Nibinator
on Apr 06, 2024 12:49pm
Something juicy is cooking
After market friday pop 100%
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Mar 26, 2024 2:56pm
LGVN....last call for alcohol
34 cents....RS effective 2morrow
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 26, 2024 1:17pm
RE:RE:LGVN.....my bid is in sub 40 pesos....again ; )
35 cents now
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Mar 26, 2024 12:22pm
RE:LGVN.....my bid is in sub 40 pesos....again ; )
Didn't get a fill yesterday No positon today Watching this retrace to 36 cents now
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >